Krystal Biotech, Inc. KRYS Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s common stock, par value (in dollars per share)?
- Krystal Biotech, Inc. (KRYS) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Krystal Biotech, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Krystal Biotech, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Krystal Biotech, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.